Back to Explorer
Healthcare & Life Sciences

Surgical Table Market Intelligence: Size, Share and Growth Outlook Through 2035

By product type, device type, material, and end use across hospital and ambulatory settings

By Brevintel Editor•September 2026•PDF + Excel

Market Size (2025)

$1.57B

Market Forecast (2035)

$2.2B

CAGR (2026-2035)

3.4%

Brevintel analysis values the surgical table market at USD 1.57 billion in 2025 ($1.57B), with an estimated USD 1.64 billion in 2026 and a path to USD 2.2 billion by 2035 ($2.2B) at a 3.4% CAGR for 2026-2035. The 3.37% mix-view CAGR is consistent with a stable equipment category in which procedure volumes and operating-room modernization create demand while capital budgets constrain purchases. Powered tables already represent 85.22% of demand, electric systems account for 49.37% of powered-table sales, and STERIS Healthcare led with over 10% share in 2025 as the top five held 38%. Metal tables retain 68.81% versus 31.19% for composites, North America accounted for 31.73% of 2023 demand, and hospitals and clinics held 65.1% of 2025 demand alongside a 65.71% related mix reading.

Surgical Table Market Intelligence: Size, Share and Growth Outlook Through 2035

Key Market Trends & Insights

  • Headline cards list $1.57B, $2.2B, and 3.4% CAGR, with USD 1.57 billion in 2025, USD 1.64 billion in 2026, USD 2.2 billion by 2035, and a 3.37% mix-view CAGR.
  • STERIS Healthcare led with over 10% share in 2025; GETINGE, Stryker, STERIS Healthcare, Baxter, and MIZUHO OSI collectively held 38%.
  • Powered tables were 85.22% of demand in 2023; electric systems were 49.37% of powered sales, hydraulic 28.57%, hybrid 22.06%, and non-powered tables 14.78%.
  • Metal tables held 68.81% versus 31.19% for composites, with pure carbon-fiber cost near USD 217 per kilogram.
  • General tables were 45.19% of 2023 demand, specialty 37.42%, radiolucent 12.50%, and pediatric 4.89%.
  • Hospitals and clinics were 65.1% of 2025 demand (65.71% in a related mix reading); ASCs were 28.24% and other end users 6.05%.
  • North America accounted for 31.73% of 2023 demand; U.S. Medicare-certified ASCs rose from 6,308 in 2023, with 250 openings that year, to 6,436 in 2024.
  • Procedure context includes 593,500 IFSO registry cases across 37 countries in 2023 (60.4% sleeve gastrectomy), 30.5 million orthopedic procedures in 2024, more than 270,000 U.S. bariatric cases in 2023, and 15.8 million cosmetic surgical procedures globally.

Market Overview

Size, mix, and purchasing shift

  • Brevintel analysis values the surgical table market at USD 1.57 billion in 2025 ($1.57B), advancing to USD 2.2 billion by 2035 ($2.2B) at a 3.4% CAGR for 2026-2035.
  • An intermediate reading of USD 1.64 billion in 2026 sits on that path from the 2025 base to the 2035 outlook.
  • A 3.37% CAGR in the equipment-mix view is consistent with a stable capital category rather than a unit-volume surge.
  • Powered tables already represent 85.22% of demand, and electric systems account for 49.37% of powered-table sales.
  • STERIS Healthcare led with over 10% share in 2025, while GETINGE, Stryker, STERIS Healthcare, Baxter, and MIZUHO OSI collectively held 38%.
  • Demand is tied to the number and clinical complexity of procedures in hospital operating rooms and ambulatory settings.
  • Tables now function as workflow equipment: powered movement, modular accessories, radiolucent sections, and position-memory affect access, imaging, anesthesia, and room turnover.
  • Buyers are no longer deciding whether powered positioning is useful; the question is whether a facility can justify electric control, radiolucency, robotic compatibility, and specialty accessories.

Procedure mix and regulation

  • The IFSO Global Registry recorded 593,500 bariatric and metabolic procedures across 37 participating countries in 2023.
  • Sleeve gastrectomy accounted for 60.4% of primary procedures in the 9th IFSO Global Registry Report 2024.
  • Global orthopedic procedure volumes were estimated to reach 30.5 million in 2024, another material source of table demand.
  • U.S. bariatric activity exceeded 270,000 procedures in 2023, based on ASMBS estimates spanning 2011-2023.
  • Bariatric, orthopedic, spine, and image-guided cases place different demands on load capacity, articulation, and imaging access.
  • Premium electric tables with carbon-fiber imaging surfaces are used where robotic surgery, fluoroscopy, CT, or O-arm workflows justify higher capital spend.
  • Standard electro-hydraulic and metal-framed systems remain commercially important where hospitals need broad coverage, local service, and lower acquisition cost.
  • U.S. operating tables are regulated under 21 CFR §878.4960, while European market access is governed by Regulation (EU) 2017/745.

Market Dynamics

Demand drivers

  • Growing procedure volumes create replacement demand in mature hospital systems and first-installation demand in facilities adding operating rooms.
  • Orthopedic volumes of 30.5 million in 2024 and 593,500 IFSO registry procedures show why load, articulation, and imaging access are not interchangeable across specialties.
  • Hospitals with high bariatric volumes have a clear case for tables designed for higher patient weights and extended positional range.
  • Baxter's TS7000dV Surgical Table was developed with Intuitive Surgical for Integrated Table Motion with da Vinci Xi systems, including a February 2023 Asia training-center appearance.
  • Radiolucent tabletops and digitally controlled positioning can reduce intra-procedure repositioning where C-arms, CT, fluoroscopy, or navigation are installed.
  • European healthcare expenditure reached €1.72 trillion in 2023, with hospitals representing 36.8% of expenditure and supporting renovation-led electric and imaging-compatible purchases.
  • India received approximately 635,000 medical tourists in 2023, supporting surgical-capacity investment among providers serving international and domestic patients.
  • Medicare-certified ASCs in the United States increased to 6,308 in 2023, with 250 facilities opening during the year, and the count reached 6,436 in 2024.
  • ASCs typically need a table that can cover several procedure categories in a constrained footprint, raising the value of accessory compatibility and rapid positioning.
  • In Asia Pacific and the Middle East, new hospital construction and private-provider investment often favor metal-framed or hybrid platforms at a lower capital threshold.

Cost constraints

  • Composite surgical tables offer radiolucency that is valuable for imaging-intensive procedures, but cost limits adoption where acquisition price and maintainability dominate.
  • A materials assessment reported a pure carbon-fiber cost of approximately USD 217 per kilogram, which constrains how fast radiolucent platforms displace metal configurations.
  • Composite tables hold 31.19% of demand, compared with 68.81% for metal tables, an operational signal that imaging compatibility is required in selected rooms only.
  • Metal construction remains commercially durable through familiar maintenance practices, robust load-bearing performance, and a lower entry price for general surgery.
  • Brevintel analysis indicates the principal tension is between the operational case for advanced positioning and the capital capacity to procure it.
  • The 3.37% CAGR is consistent with procedure volumes and operating-room modernization creating demand while budget discipline constrains purchases.
  • Paired with the 85.22% powered-table share, complex-procedure sites have stronger incentives to buy electric, specialty, and radiolucent platforms.
  • Suppliers that offer modular upgrades, durable service support, and a clear clinical-use case are better placed than vendors selling premium specifications without a total-ownership path.

Segmentation Analysis

Product type

  • General surgical tables accounted for 45.19% of global demand in 2023 across general surgery, gynecology, ENT, ophthalmology, and routine orthopedic procedures.
  • For hospitals with mixed case loads, the principal criterion is breadth of use: configurable bases, interchangeable accessories, and dependable powered adjustment.
  • Specialty surgical tables represented 37.42% of the market, including orthopedic, bariatric, neurologic, urologic, and other procedure-focused platforms.
  • More than 270,000 U.S. bariatric procedures in 2023 illustrate the clinical volume supporting high-capacity specialty positioning equipment.
  • Pediatric surgical tables held 4.89% of demand, concentrated in children's hospitals and tertiary centers rather than standard operating rooms.
  • Radiolucent surgical tables accounted for 12.50% of the market by minimizing X-ray attenuation during fluoroscopic and image-guided procedures.
  • Stille's partnerships with major imaging-system companies show the close relationship between C-arm workflow and table selection in interventional settings.
  • Brevintel analysis sees three purchasing cycles: replacement-led general rooms at 45.19%, a premium specialty and radiolucent layer, and access-led first installations.

Device type

  • Powered surgical tables represented 85.22% of the market in 2023, indicating that powered positioning is now the standard hospital configuration.
  • Electric systems held 49.37% of powered-table demand, supporting programmable positioning, repeatable settings, and digitally connected OR workflows.
  • Hydraulic systems held 28.57% of powered-table demand where robust load handling, familiar maintenance, and lower complexity are favored.
  • Hybrid systems held 22.06% of powered-table demand by combining elements of electric and hydraulic actuation at a moderated capital outlay.
  • Non-powered tables accounted for 14.78% of demand in lower-acuity procedural environments where powered systems are not economically justified.
  • Hybrid platforms remain commercially relevant in cost-sensitive hospitals and upper-tier emerging-market facilities moving beyond manual equipment.

Material

  • Metal tables held 68.81% of the global market, with stainless steel, aluminum, and other metallic structures remaining prevalent for durability and service familiarity.
  • Composite systems represented 31.19% of demand, with radiolucent properties supporting fluoroscopy, CT, O-arm, and other image-guided workflows.
  • Pure carbon-fiber cost near USD 217 per kilogram, plus engineering, validation, service, and inventory requirements, slows composite displacement of metal.
  • Hybrid composite design is particularly relevant because it can reduce material intensity while preserving some clinical benefits of carbon-fiber structures.
  • For general procedures without demanding intraoperative imaging, metal platforms can meet clinical requirements without the composite price premium.

End use

  • Hospitals and clinics accounted for 65.1% of market demand in 2025, remaining the largest channel for high-acuity, emergency, and specialty procedures.
  • A related mix reading of 65.71% for hospitals and clinics underscores the same hospital-led replacement, robotics, and imaging-integration cycle.
  • ASCs represented 28.24% of demand, shifting emphasis toward versatile platforms that can support multiple specialties in a compact operating-room bay.
  • Other end users accounted for 6.05% of demand, including specialty clinics, military facilities, and research settings.
  • The International Society of Aesthetic Plastic Surgery reported 15.8 million cosmetic surgical procedures globally in 2023, supporting outpatient surgical infrastructure.
  • Large hospitals also tend to buy tables as part of operating-room renovation, robotics deployment, imaging expansion, or equipment-standardization programs.
  • The U.S. ASC base of 6,436 Medicare-certified facilities in 2024 reinforces the importance of accessory ecosystems and responsive maintenance support.
  • Suppliers that differentiate accessories, service responsiveness, and upgrade paths can participate in both hospital and ASC channels without one capital specification.

Regional Outlook

North America and Europe

  • North America accounted for 31.73% of global surgical table demand in 2023, combining mature hospital infrastructure with a large and expanding ASC base.
  • The United States had 6,436 Medicare-certified ASCs in 2024, creating replacement demand for powered, electric, specialty, and imaging-compatible platforms.
  • U.S. operating-table market access follows 21 CFR §878.4960 on a Class I pathway, providing a defined regulatory framework for suppliers.
  • Canadian procurement remains public-system led, with electric-table penetration growing but moderated by capital allocation in provincial health authorities.
  • European Union healthcare expenditure reached €1.72 trillion in 2023, with hospitals representing 36.8% of expenditure.
  • Germany, the United Kingdom, France, Spain, Italy, and the Netherlands are key procurement markets, while Central and Eastern Europe offers incremental upgrade demand.
  • Regulation (EU) 2017/745 requires conformity documentation and, for applicable classifications, Notified Body oversight, raising the value of established quality systems.
  • The United Kingdom combines NHS hospital procurement with a growing private surgical sector and post-Brexit alignment under UK MDR.
  • The Netherlands is notable for hybrid OR investment in university medical centers, supporting higher-specification table packages.
  • European procurement also creates opportunities for regional manufacturers that can bundle tables, lighting, pendants, and modular OR infrastructure.

Asia Pacific, Latin America, and Middle East & Africa

  • Asia Pacific combines premium replacement demand in Japan, Australia, and South Korea with new-installation demand in China and India.
  • India received approximately 635,000 medical-tourist arrivals in 2023, reinforcing private-hospital surgical-capacity investment.
  • India also combines domestic manufacture such as Narang Medical with import growth under CDSCO oversight.
  • Japan is a mature, premium-oriented market with high surgical volumes, a PMDA pathway, and preference for Japanese and global brand equipment.
  • China is the largest Asia Pacific market, with a massive hospital base and government-driven OR modernization that increasingly balances quality and price.
  • Brazil is the dominant Latin American market, with a large hospital base and a growing private OR sector that has appetite for premium procurement.
  • Mexico is a significant and growing market, supported by cross-border medical tourism and government IMSS hospital modernization programs.
  • Argentina remains a relevant secondary market, although macroeconomic volatility can extend replacement cycles and defer capital purchases.
  • Middle East demand is concentrated in Saudi Arabia and the UAE, where Vision 2030 and medical-hub investment support higher-value specifications.
  • South Africa is the most developed sub-Saharan market, with the private hospital sector driving specialty table demand.
  • Across much of Africa, durable, serviceable metal and manual systems remain important where budgets, maintenance capacity, and supply chains are constrained.
  • Brevintel analysis expects regional growth to stay divided between premium replacement markets and capacity-expansion markets that need value-tier powered platforms.

Competitive Landscape

Structure and recent developments

  • STERIS Healthcare led with over 10% share in 2025, and GETINGE, Stryker, STERIS Healthcare, Baxter, and MIZUHO OSI collectively held 38%.
  • ALVO Medical designs tables within turnkey OR solutions and reports more than 3,000 modular operating-room projects in over 100 countries.
  • AMTAI Medical Equipment supplies electro-hydraulic surgical tables and accessories at a value-oriented price point, including systems with electro-hydraulic and manual operation.
  • Baxter's TruSystem business was strengthened through the Hillrom acquisition, and the TS7000dV platform provides Integrated Table Motion for da Vinci Xi procedures.
  • FAMED Lodz is an ISO 13485-certified Polish manufacturer of operating tables and surgical lighting for Poland, Central and Eastern Europe, and export markets.
  • Getinge's Maquet portfolio within Surgical Workflows reported 15.6% organic growth in the fourth quarter of 2023, with tables among important product categories.
  • Getinge introduced the Maquet Corin operating-room table in India during August 2024, emphasizing sensor-based safety functions and configurable user sequences.
  • medifa GmbH develops mobile and carbon-fiber operating tables, accessories, and surgical lights in Germany, positioning it in the radiolucent category.
  • Merivaara was acquired by Lojer Oy in June 2022, giving the company a broader hospital-furnishing and operating-room equipment platform.
  • Mizuho OSI focuses on specialty positioning, including the Hana Orthopedic Surgery Table and ProAxis Spinal Surgery Table for controlled spinal flexion and extension.
  • SKYTRON supplies imaging-capable, low-profile, and high-load tables, including the Hercules table rated for a 1,200 lb maximum permissible load.
  • STERIS 4095 General Surgical Table includes an imaging window, carbon-fiber leg section, and tabletop-slide features; Stille's imagiQ and MedStone brands partner with GE HealthCare, Philips, Ziehm Imaging, and Siemens Healthineers, while Stryker sells tables within MedSurg and the Mako ecosystem and Narang Medical exports value-oriented tables from India.

Integrated producers

  • GETINGE
  • Stryker
  • STERIS Healthcare
  • Baxter

Specialty suppliers

  • MIZUHO OSI
  • SKYTRON
  • Stille
  • medifa GmbH
  • ALVO Medical

Regional players

  • AMTAI Medical Equipment
  • FAMED Lodz
  • Merivaara
  • Narang Medical

Key Companies Covered

GETINGE
Stryker
STERIS Healthcare
Baxter
MIZUHO OSI
ALVO Medical
AMTAI Medical Equipment
FAMED Lodz
medifa GmbH
Merivaara
Narang Medical
SKYTRON
Stille

Table of Contents

The complete report includes additional chapters, data tables, and company profiles beyond this preview.

1. Market Overview

  • Size to 2035 and powered mix
  • Procedure volumes and regulation

2. Market Dynamics

  • Procedure growth, ASC expansion, and infrastructure spend
  • Composite cost and capital constraints

3. Segmentation Analysis

  • Product type, device type, material, and end use

4. Regional Outlook

  • North America and Europe
  • Asia Pacific, Latin America, and Middle East & Africa

5. Competitive Landscape

  • Share structure and recent developments
  • Integrated, specialty, and regional suppliers

Frequently Asked Questions

Access the Complete Report

Get full access including detailed market analysis, competitive positioning, and strategic recommendations.

Related Reports

Explore the latest research from this industry.

Antifungal Drugs Market Intelligence: Size, Share and Growth Outlook Through 2035

Published: September 2026

Insulin Market Intelligence: Size, Share and Growth Outlook Through 2035

Published: September 2026

Critical Care Devices Market Intelligence: Size, Share and Growth Outlook Through 2035

Published: September 2026

Lipid Nanoparticles Market Intelligence: Size, Share and Growth Outlook Through 2035

Published: September 2026

Recommended Reports

Discover other market intelligence selected based on relevance and market trends.

Specialty Vegetable Seeds Market Intelligence: Size, Share and Growth Outlook Through 2035

Published: September 2026

Seed Encapsulation Materials Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026

Royal Icing Mixes Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026

Root Microbiome Boosters Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026